|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
0.04/0.08
|
企业价值
2.52B
|
资产负债 |
每股账面净值
0.07
|
现金流量 |
现金流量率
--
|
损益表 |
收益
1.09B
|
每股收益
7.47
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/06/25 01:19 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world. |